ArticleStem cell research & therapy2023

Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.

Ridhima Vij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.